Clinical Trials · NCT03041792
Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Pfizer
- Enrollment
- 61
- Start date
- Feb 2017
- Locations
- 1 site, United States
- Primary endpoint
- Change From Baseline (Visit 3) in Mean Energy Intake During Ad Libitum Lunches at Visits 4 and 5